ArticlePharmacogenomics and personalized medicine2022

Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL.

Jian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.